Frontlight ResearchEarly access
WithdrawnNo phase
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obsessive-Compulsive Disorder
Key facts
- Who runs it
- ProgenaBiome
- Where
- Ventura, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 2 Mar 2020
- Expected to end
- Jul 2030
- Type of study
- Observational
- Record updated
- 5 June 2025
- Why it stopped
- Company shifted focus
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study; May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
- Male or female of all ages
- OCI greater than or equal to 21
Who cannot take part
- Participation in any experimental drug protocol within the past 12 weeks
- Treatment with total parenteral nutrition
- History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy
- Refusal to sign informed consent form
- Postoperative stoma, ostomy, or ileoanal pouch
Where in United States
- ProgenaBiomeVentura, United States
About the trial
What the trial wants to find out
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
The group in the trial
- Obsessive-Compulsive Disorder
Patients with obsessive-compulsive disorder
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obsessive-Compulsive Disorder (OCD)
- Record updated
- 5 June 2025